| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.23 | 6e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |